Dr. Michael Rotkowitz on the Dabrafenib Plus Trametinib Combination for Melanoma
by on Saturday, May 19th, 2012 | No Comments
Michael Rotkowitz, MD, medical oncologist, Cancer Treatment Centers of America, Eastern Regional Medical Center, discusses bypassing resistance in patients with melanoma that are receiving vemurafenib. Read more at www.onclive.com
View original post here: Dr. Michael Rotkowitz on the Dabrafenib Plus Trametinib Combination for Melanoma
